Microchip Technology — Nov 6, 2025 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000827054-25-000182
Showing in the filing
Assumed average stock price
“between $60 and $70 per share”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 25
Net sales for Q3 FY2026
“$1.129 billion plus or minus $20 million”
Quarterly dividend on common stock
“45.5 cents per share”
Quarterly dividend on Series A Mandatory Con… for FY2025
“$18.750 per share (which represents $0.9375 per depositary share)”
Gross Profit (GAAP) for Q3 FY2026
“56.2% to 58.1%”
Gross Profit (Non-GAAP) for Q3 FY2026
“57.2% to 59.2%”
Operating Expenses (GAAP) for Q3 FY2026
“47.9% to 48.5%”
Operating Expenses (Non-GAAP) for Q3 FY2026
“32.3% to 32.7%”
Operating Income (GAAP) for Q3 FY2026
“7.7% to 10.3%”
Operating Income (Non-GAAP) for Q3 FY2026
“24.5% to 26.9%”
Other Expense, net (GAAP) for Q3 FY2026
“$55.9 to $56.5 million”
Other Expense, net (Non-GAAP) for Q3 FY2026
“$55.7 to $56.7 million”
Income Tax Provision (GAAP) for Q3 FY2026
“$14.6 to $24.9 million”
Income Tax Provision (Non-GAAP) for Q3 FY2026
“$22.0 to $26.0 million”
Net income (GAAP) for Q3 FY2026
“$14.6 to $37.3 million”
Net income (Non-GAAP) for Q3 FY2026
“$193.0 to $227.4 million”
Dividends on Series A Preferred Stock (GAAP) for Q3 FY2026
“$(27.8) million”
Net (loss) income attributable to common sto… for Q3 FY2026
“$(13.2) to $9.5 million”
Net (loss) income attributable to common sto… for Q3 FY2026
“$193.0 to $227.4 million”
Diluted Common Shares Outstanding (GAAP) for Q3 FY2026
“Approximately 540.8 to 545.2 million shares”
Diluted Common Shares Outstanding (Non-GAAP) for Q3 FY2026
“Approximately 568.3 to 569.3 million shares”
Diluted net (loss) income per common share (… for Q3 FY2026
“$(0.02) to $0.02”
Diluted net (loss) income per common share (… for Q3 FY2026
“$0.34 to $0.40”
Capital expenditures for FY2025
“between $15 million and $25 million”
Capital expenditures for FY2026
“at or below $100 million”
Assumed average stock price for FY2025
“between $60 and $70 per share”
Exhibit 99.1 · the passage around this item
… earlier in the release
- - more - - Microchip Technology Reports Second Quarter Fiscal 2026 Financial Results Page 6 Diluted Common Shares Outstanding can vary for, among other things, the trading price of our common stock, the vesting of restricted stock units, the potential for incremental dilutive shares from our convertible debentures and our mandatory convertible preferred stock (additional information regarding our share count is available in the investor relations section of our website under the heading "Supplemental Information"), and repurchases or issuances of shares of our common stock. The diluted common shares outstanding presented in the guidance table above assumes an average Microchip stock price in the December 2025 quarter between $60 and $70 per share (however, we make no prediction as to what our actual share price will be for such period or any other period). - - more - - Page 7 MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share amounts; unaudited) Three Months Ended September 30, Six Months Ended September 30, 2025 2024 2025 2024 Net sales $ 1,140.4 $ 1,163.8 $ 2,215.9 $ 2,405.1 Cost of sales 502.5 495.3 1,001.3 999.7 Gross profit 637.9 668.5 1,214.6 1,405.4 Research and development 262.3 240.7 517.8 482.4 Selling, general and administrative 172.3 157.0 331.6 307.5 Amortization of acquired intangible assets 108.1 122.7 215.7 245.7 Special charges and other, net 6.3 1.5 28.5 4.1 Operating expenses 549.0 521.9 1,093.6 1,039.7 Operating income 88.9 146.6 121.0 365.7 Other expense, net (57.1) (55.1) (105.0) (112.4) Income before income taxes 31.8 91.5 16.0 253.3 Income tax (benefit) provision (9.9) 13.1 (7.1) 45.6 Net income 41.7 78.4 23.1 207.7 Dividends on Series A Preferred Stock (27.8) — (55.6) — Net income (loss) attributable to common stockholders $ 13.9 $ 78.4 $ (32.5) $ 207.7 Basic net income
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.